Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

For treating hereditary transthyretin-related amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

Pack
Pre-filled pen 45 mg in 0.8 ml Solution